Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FCRE2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,406
Award facts
- Contract value 100% obligated
- $26,406.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 200-unit vials of BOTOX on October 22, 2025. This firm fixed-price delivery order, valued at $26,406.40, is structured with an ultimate completion date of November 13, 2025, and represents one of numerous orders issued to the vendor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award utilized no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency, which carries a $499.99 billion ceiling value and extends through December 31, 2036. The underlying IDC, established as part of the broader $30.3 billion PPV-G GEN V acquisition strategy, authorizes DLA to procure a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's substantial federal contracting activity and established performance across multiple therapeutic categories position the company as a critical supplier within the DoD's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCRE2?
SPE2DR26FCRE2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FCRE2 worth?
The government has obligated $26,406 on SPE2DR26FCRE2.
Is contract SPE2DR26FCRE2 an order under another contract?
Yes. SPE2DR26FCRE2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRE2 competed?
The extent of competition for SPE2DR26FCRE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award